SYK inhibitor fostamtinib protects from early but not established atherosclerosis when local macrophage proliferation dominates lesion turnover

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Best Posters session 3 - Best Posters in atherosclerosis Atherosclerosis ESC Premium Access ESC Congress 2016

ESC 365 is supported by

ESC 365 is supported by